{"entity":{"type":"insider","cik":"0001840110","url":"/insider/0001840110","json_url":"/insider/0001840110.json","name":"Hewes L. Becker","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":14,"first":"2021-09-17","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Hewes L. Becker","source":"filing","n_filings":14,"first_seen":"2021-09-17","last_seen":"2025-03-07"}],"transactions":[{"id":4919413,"accession":"0001415889-25-007407","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-007407","line_url":"/filing/0001415889-25-007407","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5232.0,"shares_display":"5,232","price_per_share":87.69197247706423,"price_display":"87.69","price_state":"stated","total_value":458804.4,"total_display":"458,804.40","total_whole":"458,804","shares_owned_after":32960.0,"shares_owned_after_display":"32,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider","n_lines":2},{"id":4919404,"accession":"0001415889-25-007407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007407","line_url":"/filing/0001415889-25-007407#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4863.0,"shares_display":"4,863","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":431834.4,"total_display":"431,834.40","total_whole":"431,834","shares_owned_after":35651.0,"shares_owned_after_display":"35,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2189951,"accession":"0001415889-24-015734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015734","line_url":"/filing/0001415889-24-015734#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2424.0,"shares_display":"2,424","price_per_share":104.91,"price_display":"104.91","price_state":"stated","total_value":254301.84,"total_display":"254,301.84","total_whole":"254,302","shares_owned_after":29514.0,"shares_owned_after_display":"29,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2899861,"accession":"0001415889-24-015315","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-24-015315","line_url":"/filing/0001415889-24-015315","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4922.0,"shares_display":"4,922","price_per_share":106.43,"price_display":"106.43","price_state":"stated","total_value":523848.46,"total_display":"523,848.46","total_whole":"523,848","shares_owned_after":33889.0,"shares_owned_after_display":"33,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider","n_lines":2},{"id":2899854,"accession":"0001415889-24-015315","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-015315","line_url":"/filing/0001415889-24-015315","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34108.0,"shares_display":"34,108","price_per_share":105.91297232320863,"price_display":"105.91","price_state":"stated","total_value":3612479.66,"total_display":"3,612,479.66","total_whole":"3,612,480","shares_owned_after":43202.0,"shares_owned_after_display":"43,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider","n_lines":4},{"id":2069397,"accession":"0001415889-24-007562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007562","line_url":"/filing/0001415889-24-007562#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3097.0,"shares_display":"3,097","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":280866.93,"total_display":"280,866.93","total_whole":"280,867","shares_owned_after":46281.0,"shares_owned_after_display":"46,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":8231845,"accession":"0001415889-23-009402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009402","line_url":"/filing/0001415889-23-009402#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1404.0,"shares_display":"1,404","price_per_share":52.05,"price_display":"52.05","price_state":"stated","total_value":73078.2,"total_display":"73,078.20","total_whole":"73,078","shares_owned_after":36878.0,"shares_owned_after_display":"36,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8561190,"accession":"0001415889-23-004563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004563","line_url":"/filing/0001415889-23-004563","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1514.0,"shares_display":"1,514","price_per_share":45.68988110964333,"price_display":"45.69","price_state":"stated","total_value":69174.48,"total_display":"69,174.48","total_whole":"69,174","shares_owned_after":38330.0,"shares_owned_after_display":"38,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6409768,"accession":"0001415889-22-006307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-006307","line_url":"/filing/0001415889-22-006307#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3155.0,"shares_display":"3,155","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":189300.0,"total_display":"189,300.00","total_whole":"189,300","shares_owned_after":27296.0,"shares_owned_after_display":"27,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider"},{"id":6409762,"accession":"0001415889-22-006307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-006307","line_url":"/filing/0001415889-22-006307#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1220.0,"shares_display":"1,220","price_per_share":59.76,"price_display":"59.76","price_state":"stated","total_value":72907.2,"total_display":"72,907.20","total_whole":"72,907","shares_owned_after":30451.0,"shares_owned_after_display":"30,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6286777,"accession":"0001415889-22-003186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-003186","line_url":"/filing/0001415889-22-003186#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2219.0,"shares_display":"2,219","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":133140.0,"total_display":"133,140.00","total_whole":"133,140","shares_owned_after":31671.0,"shares_owned_after_display":"31,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":6710646,"accession":"0001415889-22-002734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002734","line_url":"/filing/0001415889-22-002734#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1047.0,"shares_display":"1,047","price_per_share":56.19,"price_display":"56.19","price_state":"stated","total_value":58830.93,"total_display":"58,830.93","total_whole":"58,831","shares_owned_after":33890.0,"shares_owned_after_display":"33,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":5372491,"accession":"0001179110-21-011105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-011105","line_url":"/filing/0001179110-21-011105#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":72900.0,"total_display":"72,900.00","total_whole":"72,900","shares_owned_after":26187.0,"shares_owned_after_display":"26,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":4879649,"accession":"0001179110-21-010209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-010209","line_url":"/filing/0001179110-21-010209#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":115.49,"price_display":"115.49","price_state":"stated","total_value":84192.21,"total_display":"84,192.21","total_whole":"84,192","shares_owned_after":26187.0,"shares_owned_after_display":"26,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":4520322,"accession":"0001179110-21-009515","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-009515","line_url":"/filing/0001179110-21-009515#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":102.66,"price_display":"102.66","price_state":"stated","total_value":74839.14,"total_display":"74,839.14","total_whole":"74,839","shares_owned_after":26187.0,"shares_owned_after_display":"26,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider"},{"id":4320608,"accession":"0001179110-21-008827","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-21-008827","line_url":"/filing/0001179110-21-008827","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11833.0,"shares_display":"11,833","price_per_share":101.16951407081889,"price_display":"101.17","price_state":"stated","total_value":1197138.86,"total_display":"1,197,138.86","total_whole":"1,197,139","shares_owned_after":28121.0,"shares_owned_after_display":"28,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider","n_lines":4},{"id":5143200,"accession":"0001179110-21-008826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-008826","line_url":"/filing/0001179110-21-008826#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001840110","owner_name":"Hewes L. Becker","owner_display_name":"Hewes L. Becker","owner_url":"/insider/0001840110","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1292.0,"shares_display":"1,292","price_per_share":89.03,"price_display":"89.03","price_state":"stated","total_value":115026.76,"total_display":"115,026.76","total_whole":"115,027","shares_owned_after":29270.0,"shares_owned_after_display":"29,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":14,"first_seen":"2021-09-17","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001840110","retrieved_at":"2026-08-24T00:56:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}